Two Sigma Securities »

Ovid Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 12k 1.30

More positions owned by Two Sigma Securities

Ishares Core Msci Emkt (IEMG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cme (CME)
Fox Corp Cl A Com (FOXA)
Home Depot (HD)
Ishares Tr Broad Usd High (USHY)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Capital One Financial (COF)

View all positions for Two Sigma Securities

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Assenagon Asset Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company

View all funds holding Ovid Therapeutics